Discover trends, market shifts, and competitive outlooks for the opioid use disorder (oud) industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has The Opioid Use Disorder (OUD) Market Size Shifted, And What Is the Outlook Through 2034?

In the recent past, there has been a notable acceleration in the market size of opioid use disorder (OUD). It is projected that the market, which is valued at $3.96 billion in 2024, will escalate to $4.39 billion in 2025, registering a compound annual growth rate (CAGR) of 10.9%. The growth observed in the earlier period can be traced back to factors such as high prescription rates, effective pain management techniques, strategic drug marketing, and the stigma associated with addiction.

Expectations are high for the opioid use disorder (OUD) market to experience significant expansion in the forthcoming years, with projections suggesting a growth to $6.94 billion by 2029, registering a compound annual growth rate (CAGR) of 12.1%. The anticipated growth within the forecast period can be linked to factors like regulatory measures, emphasis on alternative pain management strategies, widened scope of treatment access, and public health campaigns. Key trends emerging in the forecast period encompass advancements in treatment technology, personalized treatment techniques, the adoption of integrated care models, the establishment of community-based support schemes, and a higher degree of early intervention and prevention.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

Which Factors and External Forces Are Driving Demand in the Opioid Use Disorder (OUD) Market?

The escalating cases of opioid addiction are anticipated to fuel the expansion of the opioid use disorder (OUD) market. A medical condition marked by obsessive and consistent use of opioids leading to harmful effects defines opioid addiction. These substances have the capability to generate feelings of euphoria and relieve pain, but their sustained use can lead to tolerance, necessitating larger doses to achieve the desired result, potentially resulting in opioid use disorder. For example, the Centers for Disease Control and Prevention, a health agency based in the United States, noted a surge of 4.1% in synthetic opioid drug overdosage rates in March 2024, growing from a rate of 21.8 to 22.7 between 2021 and 2022. Hence, the rising opioid addiction cases serve as a significant factor propelling the OUD market’s growth.

Which Segments in the Opioid Use Disorder (OUD) Offer the Most Growth?

The opioid use disorder (OUD) market covered in this report is segmented –

1) By Drug Type: Buprenorphine, Naltrexone, Methadone

2) By Route of Administration: Oral, Parenteral

3) By Age Group: 19 To 40, 41 To 60, 61 And Over

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:

1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film

2) By Naltrexone: Naltrexone Tablets, Vivitrol

3) By Methadone: Methadone Tablets, Methadone Oral Solution

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12586&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Opioid Use Disorder (OUD) Market?# Market?

North America was the largest region in the opioid use disorder (OUD) market in 2024. The regions covered in the opioid use disorder (OUD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which Cutting-Edge Market Trends Are Expected to Drive theOpioid Use Disorder (OUD) Market’s Growth?

A significant trend in the opioid use disorder (OUD) market is product innovation. In order to maintain their industry standing, leading companies are introducing novel products. For instance, in May 2023, Brixadi (buprenorphine) extended-release injection was given the green light by the U.S. Food and Drug Administration, a federal agency based in the U.S., for the treatment of moderate to severe opioid use disorder (OUD). Brixadi comes in two dosage variations: a weekly injection for patients who began treatment with a single dose of a transmucosal buprenorphine product or those still on the medication, and a monthly option for those who are already under medication.

View the full report here:

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

What Are the Key Elements That Define the Opioid Use Disorder (OUD) Market?

Opioid use disorder (OUD) is a chronic brain disease resulting from prolonged use of opioids, including both prescription painkillers and illegal opioids. Opioid use disorder can develop due to genetic, environmental, and behavioral factors.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12586

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model